Question 1

What is the catalog number for CLK3 (CDC-like Kinase 3, FLJ22858, PHCLK3, PHCLK3/152) (MaxLight 750) discontinued?

Accepted Answer

The catalog number for CLK3 (CDC-like Kinase 3, FLJ22858, PHCLK3, PHCLK3/152) (MaxLight 750) discontinued is 244769-ML750.

Question 2

What sizes are available for CLK3 (CDC-like Kinase 3, FLJ22858, PHCLK3, PHCLK3/152) (MaxLight 750) discontinued?

Accepted Answer

CLK3 (CDC-like Kinase 3, FLJ22858, PHCLK3, PHCLK3/152) (MaxLight 750) discontinued is available in the following size(s): 100 µL.

Question 3

Is CLK3 (CDC-like Kinase 3, FLJ22858, PHCLK3, PHCLK3/152) (MaxLight 750) discontinued in stock?

Accepted Answer

CLK3 (CDC-like Kinase 3, FLJ22858, PHCLK3, PHCLK3/152) (MaxLight 750) discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 5

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 6

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

CLK3 (CDC-like Kinase 3, FLJ22858, PHCLK3, PHCLK3/152) (MaxLight 750) discontinued

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ESR1/1935), 0.2mg/mL

PAX5 / BSAP (Early B-Cell Marker) (PCRP-PAX5-1B1), 0.2mg/mL

PAX8 (Renal Cell Marker) (PAX8/1491), CF488A conjugate, 0.1mg/mL

Cathepsin K (Marker of Tumor Invasiveness) (CTSK/2791), 1mg/mL

HCG-beta (HCGb/54), Biotin conjugate, 0.1mg/mL

RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2701), CF647 conjugate, 0.1mg/mL